OxThera AB
556681-5667ActiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2005
- Grundlagt
Nøglebeslutningstagere
Jonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Beskrivelse
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556681566701
Beslutningstagere
4 kontakter i FunnelfeedrJonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrULTRAGENYX EUROPE GMBH
1–4 medarbejdereAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
BioGaia Pharma AB
0 medarbejdereDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Sixera Pharma AB
1–4 medarbejdereSmall biotech developing first treatment for rare Netherton syndrome.
Calliditas Therapeutics AB
20–49 medarbejderePioneering novel treatments for rare renal and hepatic diseases globally.
BridgeBio International GmbH
1–4 medarbejdereDeveloping transformative medicines for rare genetic conditions quickly.
Udforsk mere
Spørgsmål om OxThera AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo